Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59,405,621
New position
Shares Held
301,215
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 58.57444018392178.ToString("F0")%
Shared 24.49147618810484.ToString("F0")%
None 16.934083627973376.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $2,080,837,635 across 16 Drug Manufacturers - General names. AZN ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
732,549 | $673,776,592 | |
| 2 | JNJ |
Johnson & Johnson
|
1,846,524 | $451,364,326 | |
| 3 | ABBV |
AbbVie Inc.
|
1,215,422 | $264,342,129 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,639,510 | $197,216,656 | |
| 5 | AMGN |
Amgen Inc
|
433,555 | $152,546,325 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,392,773 | $84,471,681 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
301,215 | $59,405,621 | |
| 8 | NVS |
Novartis AG
|
329,910 | $50,393,751 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,405,621 | 301,215 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||